Escitalopram Reduces Symptoms of Anxiety in Teens With GAD
Increasing CYP2C19 metabolism linked to reductions in escitalopram Cmax, AUC
About One in Three Multiple Sclerosis Patients Have Migraine
Pooled prevalence of migraine 31 percent in MS patients, with significant variance internationally
About Half of Waivered Clinicians Prescribe Buprenorphine for OUD
Percentages much higher for actively prescribing U.S. clinicians with 275 and 100 versus 30 patients
Electronic Alert May Cut Excessive SABA Prescribing in Asthma
Repeat SABA prescribing for patients with asthma decreased in the 12 months following the alert
Vitamin D Supplement No Benefit in Pediatric Persistent Asthma
No improvement seen compared with placebo in children with asthma and low vitamin D levels
School-Located Influenza Vaccine Intervention Beneficial
SLIV intervention linked to drop in incidence of influenza hospitalization in school-aged children, adults
Antihypertensive Agents Not Tied to Higher Risk for Depression
Depression rates down with nine antihypertensive agents, including enalapril, amlodipine, atenolol
RAAS Inhibitors May Benefit HTN Patients With COVID-19
Risk for death, death/critical outcomes lower with use of RAAS inhibitors for hypertension
Clinical Impact of Remdesivir in Moderate COVID-19 Unclear
Significant difference seen in clinical status versus usual care for five-day, but not 10-day, course
Nonopioid Pain Protocol Feasible After Sports Orthopedic Surgery
45 percent of patients did not require opioids for management of postoperative pain